French Luxury Stock News

In January 2026, Dassault Aviation société anonyme raised its 2025 net sales guidance to over €7 billion, signaling stronger anticipated revenue than previously communicated. This upward revision highlights management’s increased confidence in the company’s order visibility and demand outlook across its defense and business aviation programs. We’ll now explore how this higher 2025 sales guidance could influence Dassault Aviation’s existing investment narrative and expectations for future...

In late 2025, data from the UK used-car market showed that popular secondhand electric vehicles lost significant value, with the Renault Zoe among the models experiencing some of the sharpest price declines as manufacturers cut prices on new EVs to meet regulatory sales targets. This rapid drop in used EV prices raises questions about residual values and consumer confidence in Renault’s electric line-up at a time when the group is investing heavily in its transition to battery-powered...

Why Thales Stock Is Back in Focus After CES 2026 Thales (ENXTPA:HO) is back on investors’ radar after CES 2026 recognition for a Samsung security chip that embeds Thales’ post quantum ready operating system and cryptographic libraries to protect connected devices. See our latest analysis for Thales. Thales’ €261.6 share price sits on the back of a 15% 1 month share price return and 11% year to date share price return, while its 1 year total shareholder return of about 79% points to strong...

Orange has in early January 2026 successfully priced a US$6.00 billion multi-tranche US dollar bond issue, spanning maturities from 2029 to 2056 with fixed coupons between 4.00% and 5.75%, to fund general corporate purposes including refinancing debt linked to its planned full acquisition of MasOrange. The more than very large oversubscription and the issuer’s first US dollar deal since 2016 highlight both strong credit-market appetite for Orange paper and a deliberate move to broaden its...

If you are wondering whether Sanofi’s current share price lines up with its underlying worth, you are not alone. This article is here to unpack that question clearly. Sanofi’s share price closed at €80.78, with returns of a 4.3% decline over 7 days, 1.6% decline over 30 days, 1.9% decline year to date, 14.1% decline over 1 year, 0.4% gain over 3 years and 20.8% gain over 5 years, which may have some investors reassessing the balance between risk and opportunity. Recent news coverage around...

Ideally, your overall portfolio should beat the market average. But in any portfolio, there will be mixed results...

Why Société Générale Société anonyme (ENXTPA:GLE) Is On Investors’ Radar Société Générale Société anonyme (ENXTPA:GLE) has been drawing attention after a strong past 3 months total return of about 31%. This has prompted investors to reassess how its current share price compares with underlying fundamentals. See our latest analysis for Société Générale Société anonyme. That recent 31.1% 90 day share price return, alongside a very large 1 year total shareholder return of about 153%, suggests...

A consortium of market infrastructure and trading firms recently completed a third wave of transactions on the Canton Network, using tokenized commercial bank deposits via LSEG Digital Settlement House and tokenized collateral such as European government bonds and U.S. Treasuries for on-chain intraday repo across multiple currencies and borders. Euronext highlighted that this work is part of a broader industry push to build tokenization and on-chain infrastructure while staying aligned with...

If you are wondering whether ABIVAX Société Anonyme is priced attractively right now, it helps to separate the recent excitement from what the numbers actually say about value. The share price last closed at €103.60, with returns of 4.4% over 7 days, 10.1% over 30 days and a very large gain over the past year, although year to date the stock shows a 9.9% decline. These moves have come as ABIVAX Société Anonyme continues to attract attention in the French pharmaceuticals and biotech space,...

Media reports around Eurazeo (ENXTPA:RF) potentially exiting its investment in French beauty retailer Aroma-Zone, after several years of store expansion, have put fresh attention on how this holding fits into the group’s portfolio. See our latest analysis for Eurazeo. The Aroma-Zone headlines arrive as Eurazeo’s share price has edged higher in the very short term, with a 1-day share price return of 1.14% and 7-day share price return of 3.00%. This sits against a 90-day share price return...

In early January 2026, reports indicated that EssilorLuxottica and Meta Platforms were considering significantly increasing production capacity for their AI-powered Ray-Ban smart glasses to meet strong demand. This potential scale-up in smart glasses output highlights EssilorLuxottica’s push deeper into technology-enabled eyewear, expanding beyond traditional lenses and frames into AI wearables. We’ll now examine how this potential ramp-up in AI-powered smart glasses production could...

Eramet (ENXTPA:ERA) has become a talking point after reporting A minus scores for both Climate Change and Water Security in the 2025 Carbon Disclosure Project cycle, reinforcing attention on its “Act for Positive Mining” roadmap. See our latest analysis for ERAMET. The €85.2 share price has been moving sharply, with a 24.65% 7 day share price return and a 79.37% 30 day share price return feeding into a 58.09% 1 year total shareholder return. This suggests momentum has recently picked up as...

Legrand SA ( EPA:LR ) received a lot of attention from a substantial price movement on the ENXTPA over the last few...

Unfortunately for some shareholders, the Vusion S.A. ( EPA:VU ) share price has dived 27% in the last thirty days...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...

Wondering if BNP Paribas at €87.38 is offering good value or if the easy money has already been made? This article breaks down what the current price might really imply. The stock has seen returns of 5.9% over the last 7 days, 10.8% over the last 30 days and 54.6% over the last year, with longer term returns of 86.4% over 3 years and 178.8% over 5 years. These moves have played out alongside ongoing investor focus on large European banks and how their balance sheets, capital positions and...

In early January 2026, Pluxee N.V. reported fiscal first-quarter revenue of €308 million, up from €289 million a year earlier, and separately disclosed recent treasury share repurchase transactions. The combination of higher year-on-year revenue and continued buybacks highlights management’s focus on both growing the business and actively managing the capital structure. We’ll now examine how Pluxee’s first-quarter revenue growth shapes its investment narrative built around expansion,...

Why the new drone contracts matter for Exail shareholders Exail Technologies (ENXTPA:EXA) has just secured fresh contracts across its DriX H-9 surface drones and K-STER mine neutralization systems, putting the spotlight on how its autonomous maritime portfolio might influence the stock. See our latest analysis for Exail Technologies. The fresh DriX H-9 and K-STER contracts arrive after a strong run in the shares, with a 30-day share price return of 22.95% and a year to date share price return...

In early January 2026, Voltalia SA updated its outlook, indicating that the net loss attributable to the Group in the second half of 2025 was higher than in the first half. This guidance signals that, despite longer-term ambitions, the company faced increasing near-term pressures on profitability heading into the end of 2025. We’ll now explore how the expectation of a higher second-half 2025 net loss could influence Voltalia’s existing investment narrative. These 14 companies survived and...

As European markets start the year with optimism, the pan-European STOXX Europe 600 Index has risen by 2.27%, buoyed by positive economic signals and a favorable interest rate environment. In this context, penny stocks—often seen as relics of past market eras—continue to offer intriguing opportunities for investors seeking growth potential in smaller or newer companies. While traditionally associated with higher risk, these stocks can present compelling value when underpinned by strong...

Key Insights Cellectis' significant individual investors ownership suggests that the key decisions are influenced by...

Valeo SE ( EPA:FR ), might not be a large cap stock, but it received a lot of attention from a substantial price...

As 2026 begins, the European stock market is buoyant with optimism, as evidenced by a 2.27% rise in the STOXX Europe 600 Index, driven by strengthening economies and favorable interest rate conditions across the eurozone. In this environment of economic revival and positive sentiment, identifying stocks that exhibit strong fundamentals and growth potential becomes crucial for investors seeking opportunities in Europe's small-cap sector.

SCOR (EPA:SCR) has had a rough three months with its share price down 7.0%. But if you pay close attention, you might...